Martin J Edelman Selected Research

N- 4- ((5- bromo- 2- pyrimidoxy)- 3- methylphenyl)- (2- dimethylamino)benzoylurea

5/2007

The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin J Edelman Research Topics

Disease

79	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2002
56	Neoplasms (Cancer) 03/2022 - 01/2003
33	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2003
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2004
7	Leukemia 07/2017 - 02/2008
6	Neutropenia 01/2022 - 08/2004
6	Disease Progression 01/2015 - 08/2007
5	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2003
4	Pathologic Complete Response 01/2018 - 10/2004
4	Adenocarcinoma 10/2012 - 12/2010
3	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2003
3	Febrile Neutropenia 01/2014 - 08/2004
3	Neoplasm Metastasis (Metastasis) 10/2005 - 02/2003
3	Esophagitis 11/2004 - 02/2003
2	Anemia 01/2022 - 01/2017
2	Diarrhea 01/2022 - 02/2014
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2019
2	Carcinogenesis 01/2020 - 09/2014
2	Exanthema (Rash) 03/2019 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2017 - 09/2014
2	Esophageal Neoplasms (Esophageal Cancer) 04/2016 - 06/2006
2	Breast Neoplasms (Breast Cancer) 06/2014 - 02/2014
2	Vomiting 02/2014 - 08/2004
2	Multiple Myeloma 02/2014 - 10/2005
2	Ovarian Neoplasms (Ovarian Cancer) 11/2012 - 05/2012
2	Adenocarcinoma of Lung 10/2012 - 06/2012
2	HIV Infections (HIV Infection) 07/2008 - 04/2007
2	Carcinoma (Carcinomatosis) 05/2007 - 04/2004
2	Alopecia (Baldness) 01/2003 - 11/2002
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2022
1	Asthenia 01/2022
1	COVID-19 01/2020
1	Turcot syndrome 10/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019
1	Thromboembolism 01/2017

Drug/Important Bio-Agent (IBA)

23	PlatinumIBA 11/2020 - 01/2003
19	Carboplatin (JM8)FDA LinkGeneric 06/2013 - 11/2002
15	Gemcitabine FDA Link 04/2012 - 07/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 01/2003
13	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2006
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2019 - 07/2007
6	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2004
5	ErbB Receptors (EGF Receptor)IBA 03/2019 - 12/2005
5	Docetaxel (Taxotere)FDA Link 01/2015 - 08/2004
5	Pemetrexed (MTA)FDA Link 01/2015 - 10/2008
5	Pharmaceutical PreparationsIBA 02/2014 - 02/2003
5	taxaneIBA 05/2012 - 11/2002
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2017 - 02/2008
3	Celecoxib (Celebrex)FDA Link 07/2017 - 02/2008
3	VaccinesIBA 03/2015 - 10/2008
3	Vinorelbine (Navelbine)FDA LinkGeneric 11/2013 - 07/2002
3	ixabepilone (BMS 247550)FDA Link 06/2013 - 08/2007
3	EC145IBA 11/2012 - 05/2012
3	EicosanoidsIBA 04/2012 - 02/2008
3	Bortezomib (Velcade)FDA Link 10/2011 - 10/2005
3	SteroidsIBA 07/2003 - 11/2002
2	Peptides (Polypeptides)IBA 01/2022 - 03/2015
2	Tyrosine Kinase InhibitorsIBA 03/2019 - 06/2012
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2017 - 06/2012
2	onartuzumabIBA 02/2017 - 11/2012
2	Bevacizumab (Avastin)FDA Link 01/2017 - 07/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2016 - 11/2016
2	Protein Isoforms (Isoforms)IBA 06/2013 - 01/2012
2	TubulinIBA 06/2013 - 05/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2012 - 10/2012
2	zileuton (Zyflo)FDA Link 04/2012 - 02/2008
2	7-hydroxystaurosporine (UCN 01)IBA 05/2007 - 04/2003
2	Antisense OligonucleotidesIBA 05/2006 - 03/2004
1	Immune Checkpoint InhibitorsIBA 03/2022
1	dinutuximabIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	RadiumIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	fludarabineIBA 01/2022
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2022
1	AntigensIBA 01/2022
1	pembrolizumabIBA 10/2019
1	Cyclin-Dependent Kinase 4IBA 10/2019
1	Cyclin D3IBA 10/2019
1	palbociclibIBA 10/2019
1	Cyclin D2IBA 10/2019
1	Carbon DioxideIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018

Therapy/Procedure

51	Drug Therapy (Chemotherapy) 11/2020 - 01/2003
37	Therapeutics 03/2022 - 01/2003
17	Radiotherapy 01/2022 - 02/2003
9	Chemoradiotherapy 11/2020 - 02/2003
8	Neoadjuvant Therapy 01/2018 - 06/2003
4	Immunotherapy 01/2020 - 10/2008
4	Combined Modality Therapy 01/2019 - 02/2003
3	Cranial Irradiation 01/2021 - 01/2019
3	Aftercare (After-Treatment) 10/2019 - 02/2017
3	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 01/2004
2	Organ Transplantation 07/2008 - 01/2006
1	Time-to-Treatment 01/2018